Abstract
Sepsis, as defined by an expert consensus definition, is the development of the systemic inflammatory response syndrome in the presence of infection. Using this clinically applicable definition, several studies have evaluated the epidemiology of sepsis over the past decade. The current incidence of sepsis is at least 240 patients per 100,000 people in the United States population, whereas for severe sepsis it is between 51 and 95 patients per 100,000 people. The incidence rate for sepsis has been increasing over the past two decades, driving an increase in the number of deaths despite a decline in case-fatality rates. Sepsis is the tenth leading cause of death in the United States and accounts for more than 17 billion dollars in direct healthcare expenditures.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
Bone RC, Balk RA, Cerra FB, et al.: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644–1655. The original sepsis definition is described in this landmark paper.
BoneRC: Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 1992, 268:3452–3455.
Bernard GR, Vincent JL, Laterre PF, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699–709. This paper highlights the first pharmacologic treatment study for sepsis to show a significant benefit.
Warren BL, Eid A, Singer P, et al.: High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001, 286:1869–1878.
Abraham E, Reinhart K, Opal S, et al.: Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003, 290:238–247.
Rangel-Frausto MS, Pittet D, Costigan M, et al.: The Natural History of the Systemic Inflammatory Response Syndrome (SIRS): A Prospective Study. JAMA 1995, 273:117–123.
Brun-Buisson C, Doyon F, Carlet J, et al.: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA 1995, 274:968–974.
Sands KE, Bates DW, Lanken PN, et al.: Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997, 278:234–240.
Angus DC, Wax R: Epidemiology of sepsis: an update. Crit Care Med 2001, 29:S109-S116.
Center for Disease Control: Increase in national hospital discharge survey rates for septicemia: United States, 1979–1987. MMWR Morb Mortal Wkly Rep 1990, 39:31–34.
Angus DC, Linde-Zwirble WT, Lidicker J, et al.: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303–1310. This paper was the first to estimate the national cost of severe sepsis.
Eaton S, Burnham E, Martin GS, Moss M: The ICD-9 code for septicemia maintains a high positive predictive value for clinical sepsis [abstract]. Am J Respir Crit Care Med 2002, 165:A471.
Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546–1554. This paper covers a longitudinal study of sepsis in the United States that highlights several important trends in the epidemiology of sepsis, including racial and gender disparities.
Sundararajan V, Macisaac CM, Presneill JJ, et al.: Epidemiology of sepsis in Victoria, Australia. Crit Care Med 2005, 33:71–80.
Padkin A, Goldfrad C, Brady A, et al.: Epidemiology of severe sepsis occurring in the first 24 h in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003, 31:2332–2338.
Finfer S, Bellomo R, Lipman J, et al.: Adult-population incidence of severe sepsis in Australia and New Zealand intensive care units. Intensive Care Med 2004, 30:589–596.
Brun-Buisson C, Meshaka P, Pinton P, Vallet B: EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004, 30:580–588.
Annane D, Aegerter P, Jars-Guincestre MC, Guidet B: Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003, 168:165–172.
Zhan C, Miller MR: Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 2003, 290:1868–1874.
Annane D, Sebille V, Charpentier C, et al.: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862–871.
Bernard GR, Wheeler AP, Russell JA, et al.: The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 1997, 336:912–918.
Alberti C, Brun-Buisson C, Burchardi H, et al.: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002, 28:108–121.
Martin GS, Mannino DM, Moss M: The effect of cancer on risks and outcomes in sepsis [abstract]. Am J Respir Crit Care Med 2003, 167:A549.
Williams MD, Braun LA, Cooper LM, et al.: Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care 2004, 8:R291-R298.
Martin GS, Mannino DM, Moss M: Effect of age on the development and outcome with sepsis [abstract]. Am J Respir Crit Care Med 2003, 167:A837.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Danai, P., Martin, G.S. Epidemiology of sepsis: Recent advances. Curr Infect Dis Rep 7, 329–334 (2005). https://doi.org/10.1007/s11908-005-0005-1
Issue Date:
DOI: https://doi.org/10.1007/s11908-005-0005-1